Formic Ventures is a diversified venture capital firm that makes seed investments in biotechnology startups focused on human longevity as well as opportunistic startups that can make human lives more meaningful.
Investment Type: Venture Capital
Investment Stage: Seed
Portfolio 45
| Date | Name | Website | Total Raised | Location |
| 30.10.2023 | SAMPLING H... | samplinghuman.com | $2M | United Sta... |
| 30.10.2023 | DEEP ORIGI... | deeporigin.com | - | United Kin... |
| - | Vaxxinity | vaxxinity.com | $9.3M | United Sta... |
| - | Zerobroker... | zerobroker.com | $6.5M | - |
| - | BlockFi | blockfi.com | $528.1M | United Sta... |
| - | Aviron Act... | avironactive.com | $23.1M | Canada, On... |
| - | ZERØ | zeroapp.ai | - | United Sta... |
| - | Schrödinge... | schrodinger.com | $195M | United Sta... |
| - | Anduril In... | anduril.com | $11.13B | United Sta... |
| - | Insilico M... | insilico.com | $682M | United Sta... |
Show more
Mentions in press and media 2
| Date | Title | Description |
| 09.02.2022 | Trestle Biotherapeutics licenses kidney implant 3D bioprinting technology from Harvard | 3D Printing Industry is currently seeking feedback on material usage across the sector. Have your say in the Spotlight on Resin 3D Printing Survey now. San Diego-based bioengineering start-up Trestle Biotherapeutics has gained a license for... |
| 09.02.2021 | Nanome raises $3 million to help scientists get up close with molecular structures in VR | Discovery and research of new molecular compounds is an expensive business, with development costs exceeding $10 billion per substance in some cases. Part of that comes from the need to closely examine every relevant molecule, studying its ... |